ANTA Biotech
ANTA Biotech (styled ΛNTΛ Biotech) is an early-stage biotech startup headquartered in San Diego, California, founded by a team with UC San Diego ties.
Position in SVTR
Snapshot 2026-10-28- Startup SignalsRankedof 2,177new
- Life SciencesRankedof 231
- AI for ScienceRankedof 107
- SpaceRankedof 41
About
ANTA Biotech (styled ΛNTΛ Biotech) is an early-stage biotech startup headquartered in San Diego, California, founded by a team with UC San Diego ties. It builds automated biotools designed to operate without trained operators in extreme environments — from low Earth orbit and microgravity to remote field sites — starting with a system that automates genomic sample preparation and on-site sequencing (the "space automated genomics / DNA mining" pitch). Target use cases include space-station research, military field diagnostics, agriculture, and polar/ocean expeditions. The company has received support from NASA and NSF and is based at BioLabs San Diego.
Capital graph
Founders / team· 6
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- ANTA Biotech
ANTA Biotech (styled ΛNTΛ Biotech) is an early-stage biotech startup headquartered in San Diego, California, founded by a team with UC San Diego ties. It builds automated biotools designed to operate without trained operators in extreme environments — from low Earth orbit and microgravity to remote field sites — starting with a system that automates genomic sample preparation and on-site sequencing (the "space automated genomics / DNA mining" pitch). Target use cases include space-station research, military field diagnostics, agriculture, and polar/ocean expeditions. The company has received support from NASA and NSF and is based at BioLabs San Diego.
$3M
$3M
United States
BusinessLatest roundTotal raisedDate- LogicFlo AI
Builds AI assistants that automate research tasks for life sciences teams
Seed · $3M · 2025-07
$3M - Convoke
AI operating system for biopharma R&D that aggregates data, automates routine research tasks and generates decision and regulatory documents
Seed · $9M · 2025-08
$9M - Honey Health
AI agents that automate back-office work at healthcare providers
Seed · $8M · 2025-11
$8M
China
BusinessLatest roundTotal raisedDate- 中科欣扬
Synthetic biology platform built on extremophile microbial resources, developing bioactive ingredients for the pharmaceutical, food and cosmetics industries; commercialized products include ergothioneine, NMN and vanillin.
Series C · $42M · 2026-07
$42M - Matwings Technology
Protein design model MatwingsVenus with an automated lab platform, doing enzyme mining and directed evolution for universities and pharma companies
Series A · 2026-07
—
Europe
BusinessLatest roundTotal raisedDate- ScienceMachine
AI bioinformatics agents to automate experiments and data analysis
Pre-Seed · $4M · 2025-07
$4M - Praxipal
AI "front desk/receptionist" that automates patient communications for clinics
Seed · $7M · 2025-10
$7M - Research Grid
Automated workflow platform that improves clinical trial efficiency
Seed · $6M · 2024-11
$6M
Other / unspecified
BusinessLatest roundTotal raisedDate- Revena
Hospital billing automation
Seed · $8M · 2026-02
$8M - OutPost Bio
Automated wet lab + machine learning to generate human microbiome data and predict microbial effects of drugs/products
Pre-Seed · $7M · 2026-03
$7M - Daffodil Health
Uses AI to automate healthcare pricing and administrative tasks, lowering costs for providers
Seed · $5M · 2024-05
$5M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 22 in US West Coast
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.